Pallone: Rx Drug Price-Fixing is Reprehensible

FOR IMMEDIATE RELEASE
May 13, 2019


Washington, D.C. – Energy and Commerce Chairman Frank Pallone, Jr. (D-NJ) released the following statement after a coalition of 44 states brought an anti-trust lawsuit against 20 generic drug manufacturers and 15 individuals for a conspiracy to fix prescription drug prices for more than 100 products on the market:

“The Attorney Generals’ allegations of drug price-fixing are deeply disturbing, and I applaud their efforts to hold manufacturers accountable for subjecting American consumers to higher prescription drug prices. If true, any conspiracy to artificially drive up prices when Americans are already struggling to afford the lifesaving drugs they depend on is reprehensible.

“Generic drugs are intended to bring competition to our marketplaces and provide access to affordable medications for all Americans, but this lawsuit suggests some manufacturers may have conspired to rig the system. This behavior is unacceptable, and another example of how we must continue to find ways to prevent drug manufacturers from taking advantage of Americans.”